< Resources

Case Study

Genomenon and BeginNGS: The Promising Future of Newborn Sequencing

The new BeginNGS™ program, based at the Rady Children’s Institute for Genomic Medicine (RCIGM), is a novel health care delivery system designed to screen newborns for genetic diseases and connect their doctors with effective treatment options. It will improve infant patient outcomes by providing clinicians with powerful insight on how these diseases form, and how to treat them, creating life-saving opportunities for patients and their families at very early stages.

Mastermind: The premier resource of BeginNGS

As part of our mission to curate the entire human genome, Genomenon will combine AI-powered organization and expert manual review to fully curate all the genes in the BeginNGS screening panel – genes tied to over 400 diseases – and provide RCIGM with a comprehensive, actionable dataset on the variants that are found to cause disease. Read more here.

The World’s Most Comprehensive Source of Genomic Evidence

Mastermind accelerates variant interpretation with immediate insight into the full text of millions of scientific articles. Prioritize your search results by clinical relevance and find what you are looking for 5-10 times faster

Explore Mastermind CORE
Every Missing Genetic Variant is a Patient Your Label Doesn't Reach
  • Rare disease and precision oncology programs rely on evidence fragmented across millions of published articles and supplemental datasets.
  • Genomenon builds the custom real-world evidence your program needs.
  • AI-powered search. Expert scientific curation.
  • The result: a broader label, more eligible patients, and a regulatory filing your team can defend.
Request a custom evidence build for your program
speak with an expert